RenovoRx, Inc. (RNXT)
1.28
-0.05
(-3.76%)
USD |
NASDAQ |
Oct 09, 16:00
1.32
+0.04
(+3.12%)
After-Hours: 20:00
RenovoRx Free Cash Flow (Quarterly) : -2.938M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.938M |
| March 31, 2026 | -3.709M |
| December 31, 2025 | -3.02M |
| September 30, 2025 | -2.27M |
| June 30, 2025 | -2.302M |
| March 31, 2025 | -3.383M |
| December 31, 2024 | -2.442M |
| September 30, 2024 | -2.194M |
| June 30, 2024 | -2.297M |
| March 31, 2024 | -2.204M |
| December 31, 2023 | -2.053M |
| September 30, 2023 | -2.728M |
| June 30, 2023 | -2.771M |
| Date | Value |
|---|---|
| March 31, 2023 | -2.706M |
| December 31, 2022 | -1.681M |
| September 30, 2022 | -2.672M |
| June 30, 2022 | -2.361M |
| March 31, 2022 | -2.097M |
| December 31, 2021 | -2.558M |
| September 30, 2021 | -1.119M |
| June 30, 2021 | -1.262M |
| March 31, 2021 | -0.992M |
| September 30, 2020 | -0.691M |
| June 30, 2020 | -0.814M |
| March 31, 2020 | -1.053M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | -9.979M |
| Travere Therapeutics, Inc. | 37.00M |
| REGENXBIO, Inc. | -63.00M |
| Krystal Biotech, Inc. | 71.22M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |